FREE SHIPPING ON ORDERS OVER $150

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International HGF and MET: From Brain

$24.31

Quantity
- +
Description

Yang, X., Minn, I., Rowe, S

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International HGF and MET: From Brain

First in human dosing refers to the first dosing administered to humans to study in vivo behavior of the novel compound

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International HGF and MET: From Brain

DFAS began handling all direct SBP premium payments in-house

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International HGF and MET: From Brain

Supplementary Figure S5 Details of the three candidates of AD-classification networks (Networks used in Figure 7)

dihexa hgf c-met agonist Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International HGF and MET: From Brain

You may also like

GHK-Cu

US$ 26.53

4.6 (21 reviews)

Frontiers

US$ 27.39

4.4 (16 reviews)

recommand products